New Legacy Group’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $205K | Hold |
2,805
| – | – | 0.56% | 27 |
|
|
2023
Q2 | $233K | Hold |
2,805
| – | – | 0.59% | 26 |
|
|
2023
Q1 | $214K | Hold |
2,805
| – | – | 0.61% | 26 |
|
|
2022
Q4 | $233K | Hold |
2,805
| – | – | 0.72% | 27 |
|
|
2022
Q3 | $222K | Hold |
2,805
| – | – | 0.57% | 27 |
|
|
2022
Q2 | $208K | Hold |
2,805
| – | – | 0.42% | 27 |
|
|
2022
Q1 | $252K | Sell |
2,805
-2,700
| -49% | -$243K | 0.09% | 28 |
|
|
2021
Q4 | $616K | Buy |
+5,505
| New | +$616K | 0.12% | 17 |
|